What is LEGN's health score?

Legend Biotech Corp (LEGN) has a TradeApes health score of 38 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LEGN's estimated fair value?

Based on our 5-year discounted cash flow model, Legend Biotech Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is LEGN undervalued or overvalued?

Our model currently rates LEGN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LEGN... Refresh in a moment for the full analysis.

Legend Biotech Corp (LEGN)

Healthcare Inconclusive inconclusive weak

$34.2

Updated: 2026-06-05

TradeApes Score

Financial Strength

5 Stressed

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

40 Weak

Risk

70 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.